Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.74 is 41% above its 3-year average of 4.77, around the middle of its 3-year range (0.00–11.26).
As of the fiscal period ended Tuesday, June 30, 2026. 10.00% above its 12-month average of 6.13.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.74.
CURRENT RATIO
6.74
CURRENT RATIO AVG TTM
6.13
CURRENT RATIO AVG 3Y
4.63
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+10.00%
CURRENT VS 3Y AVG
+45.62%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.36
median of 505 covered companies
CURRENT VS SECTOR MEDIAN
+100.70%
vs the sector median at left
Market Cap
$856.30M
Current Ratio
14.93
TTM Avg
20.63
3Y Avg
16.30
5Y Avg
22.70
Market Cap
$867.60M
Current Ratio
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
Market Cap
$819.44M
Current Ratio
4.26
TTM Avg
4.46
3Y Avg
3.96
5Y Avg
4.08
Market Cap
$786.48M
Current Ratio
4.48
TTM Avg
5.45
3Y Avg
6.78
5Y Avg
8.00
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alumis Inc. (ALMS) | $844.28M | 6.74 | 6.13 | 4.63 | N/A |
| Ardelyx, Inc. (ARDX)vs › | $837.43M | 3.34 | 4.45 | 4.03 | 4.25 |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | 8.88 | 7.47 | 6.98 | 6.98 |
| Jade Biosciences, Inc. (JBIO)vs › | $856.30M | 14.93 | 20.63 | 16.30 | 22.70 |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | 9.52 | 4.26 | 6.09 | 7.80 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | 4.26 | 4.46 | 3.96 | 4.08 |
| InMode Ltd. (INMD)vs › | $812.20M | 8.18 | 10.05 | 10.24 | 9.72 |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | 4.48 | 5.45 | 6.78 | 8.00 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | 16.16 | 3.88 | 3.97 | 4.50 |
Current Ratio
6.74
Quick Ratio
6.74
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.74 |
| 2026-03-31 | 7.51 |
| 2025-12-31 | 4.34 |
| 2025-09-30 | 6.01 |
| 2025-06-30 | 6.05 |
| 2025-03-31 | 3.73 |
| 2024-12-31 | 6.01 |
| 2024-09-30 | 11.26 |
| 2024-06-30 | 6.73 |
| 2024-03-31 | 5.89 |
| 2023-12-31 | 2.56 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
